10-Q/A: U.S. Global Investors Files 10-Q/A Restating EPS

Sentiment:

Quarterly Report Amendment


U.S. Global Investors, Inc. filed an amended quarterly report to correct an error in the calculation of weighted average shares outstanding, which previously overstated earnings per share.

Worse than expectedThe filing reports a material weakness in internal control over financial reporting.The filing requires a restatement of previously reported earnings per share due to calculation errors.

Summary

  • The company filed an amendment to its Form 10-Q for the quarter ended March 31, 2026, to restate earnings per share (EPS).
  • The error involved an understatement of the weighted average number of shares outstanding, leading to an overstatement of basic and diluted EPS by $0.02 for the three months and $0.01 for the nine months ended March 31, 2026.
  • The restatement did not impact net income, revenues, expenses, financial position, or cash flows.
  • Management identified a material weakness in internal control over financial reporting related to the review of share count calculations.
  • Total assets under management (AUM) were approximately $1.4 billion as of March 31, 2026, compared to $1.2 billion in the prior-year period.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as negative due to the admission of a material weakness in internal controls and the necessity of a financial restatement, which undermines investor confidence in the accuracy of financial reporting.

Positives

  • Net income for the nine months ended March 31, 2026, was $3.3 million, a significant improvement from a net loss of $153,000 in the same period of 2025.
  • Operating revenues increased by 15.9% to $7.5 million for the nine-month period.
  • The company maintains a strong liquidity position with $24.6 million in cash and cash equivalents and a current ratio of 20.9 to 1.
  • Total AUM increased by $239.1 million year-over-year to $1.4 billion.

Negatives

  • The company reported a material weakness in internal control over financial reporting regarding the calculation of weighted average shares outstanding.
  • Operating expenses for the nine months ended March 31, 2026, were $8.0 million, though this was a decrease from the prior year.
  • The company is subject to ongoing regulatory and market risks associated with its investment management activities and indirect exposure to cryptocurrency markets.

Risks

  • Failure to remediate the identified material weakness in internal control over financial reporting could lead to further financial misstatements or regulatory scrutiny.
  • The company's financial results are highly sensitive to market volatility, which can impact AUM and management fee revenue.
  • Indirect exposure to the cryptocurrency industry through investments in issuers like HIVE introduces significant price volatility and regulatory risk.
  • The company's investment management contracts are subject to annual renewal, creating potential revenue instability.

Future Outlook

The company expects that gains and losses on investments will continue to fluctuate due to market conditions. Management is implementing remedial measures to address the material weakness in internal controls and intends to renew its credit facility biennially.

Management Comments

  • Management concluded that the previously issued financial statements should no longer be relied upon due to an error in the calculation of weighted average number of shares outstanding.
  • Management believes the revised financial statements present fairly, in all material respects, the company's financial position and results of operations.
  • Management is implementing remedial measures, including enhanced review procedures and strengthened controls over spreadsheet completeness and formula integrity.

Industry Context

StockSavvy.ai notes that U.S. Global Investors operates in a highly competitive and volatile asset management sector. The restatement highlights the operational risks inherent in smaller financial firms relying on manual spreadsheet-based reporting, a common industry vulnerability that regulators are increasingly scrutinizing.

Comparison to Industry Standards

  • The company's reliance on performance fees (now phased out) and exposure to niche sectors like precious metals and cryptocurrency mining differentiates it from traditional diversified asset managers like BlackRock or Vanguard.
  • The company's internal control failure is a significant deviation from the robust financial reporting standards expected of publicly traded financial institutions.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Internal Control RemediationImplementation of enhanced review procedures and controls over spreadsheet completeness and formula integrity.June 2026Intended to prevent future misstatements in financial reporting.

Related Party Transactions

  • The company has a lease agreement with HIVE, a company where CEO Frank Holmes serves as executive chairman.
  • The company holds equity investments in HIVE and has historically held convertible debentures issued by HIVE.

Stakeholder Impact

  • Shareholders may experience reduced confidence due to the restatement and identified material weakness.
  • The company's reputation could be impacted by the need for financial restatement.

Next Steps

  • Remediation of the material weakness in internal control over financial reporting.
  • Evaluation of the design and operating effectiveness of new internal controls.
  • Continuation of the monthly dividend of $0.0075 per share through June 2026.

Key Dates

DateDescription
2026-03-31Quarterly period end for the financial statements.
2026-05-13Original filing date of the Form 10-Q.
2026-05-29Management concluded financial statements should no longer be relied upon.
2026-06-02Filing of Form 8-K regarding the restatement.
2026-06-05Filing date of the Amendment No. 1 on Form 10-Q/A.

Recommendation

sell

The combination of a material weakness in internal controls and the need to restate earnings per share suggests significant operational deficiencies. Investors should exercise caution until the company demonstrates that its financial reporting processes are robust and reliable.

Keywords

U.S. Global Investors, GROW, 10-Q/A, Restatement, Earnings Per Share, Investment Management, Internal Control, Material Weakness

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.